Skip to content

High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)

The Effects of High-Flow Nasal Oxygen Therapy on Respiratory Complications and Post-Procedural Recovery Time in Patients Undergoing Sedated EBUS-TBNA

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07760727
Enrollment
120
Registered
2026-08-12
Start date
2026-08-20
Completion date
2026-11-20
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Flow Oxygen Therapy, ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION, Sedation, Sedation Complication, Blood Gas Analysis

Keywords

High flow oxygen therapy,, Endobronchial Ultrasound-Transbronchial Needle Aspiration(EBUS-TBNA), Sedation, Sedation Complications, Blood Gas Analysis

Brief summary

This study aims to evaluate the effects of high-flow nasal oxygen therapy on respiratory complications, blood gas parameters, and post-procedural recovery in patients undergoing sedated endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Participants will be assigned to receive either high-flow nasal oxygen therapy or conventional oxygen therapy during the procedure. The incidence of respiratory complications, blood gas changes, and recovery outcomes will be compared between the two groups.

Interventions

High-flow nasal oxygen therapy administered during sedated EBUS-TBNA procedures to provide enhanced oxygenation and respiratory support.

Conventional oxygen therapy administered during sedated EBUS-TBNA procedures using standard oxygen delivery methods

Sponsors

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age ≥18 years. Scheduled to undergo sedated EBUS-TBNA. Ability to provide written informed consent. ASA physical status I-III.

Exclusion criteria

* Age \<18 years. * Pregnancy. * Requirement for endotracheal intubation or general anesthesia. * Severe hemodynamic instability. * Refusal to participate in the study. * Contraindication to high-flow nasal oxygen therapy.

Design outcomes

Primary

MeasureTime frameDescription
Respiratory ComplicationsDuring the procedureIncidence of respiratory complications during sedated EBUS-TBNA, including hypoxemia, oxygen desaturation, apnea, airway obstruction, and the need for airway interventions.

Secondary

MeasureTime frameDescription
Oxygen partial pressure (PaO2)Baseline and within 15 minutes after completion of the endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) procedureChanges in venous oxygen partial pressure(PaO2) measured at baseline and after sedated EBUS-TBNA
Carbon dioxide partial pressure (PvCO2)Baseline and within 15 minutes after completion of the EBUS-TBNAChanges in venous carbon dioxide partial pressure (PvCO2) measured at baseline and within 15 minutes after completion of sedated EBUS-TBNA.
Venous pHBaseline and within 15 minutes after completion of the EBUS-TBNA procedure.Changes in venous pH measured at baseline and within 15 minutes after completion of sedated EBUS-TBNA
Venous Oxygen Saturation (SvO2)Baseline and within 15 minutes after completion of the EBUS-TBNA procedure.Changes in venous oxygen saturation (SvO2) measured at baseline and within 15 minutes after completion of sedated EBUS-TBNA.
Recovry TimeUp to 2 hours post-procedureTime from completion of sedated EBUS-TBNA until achievement of a Modified ALdrete Recovery Score ≥9.

Countries

Turkey (Türkiye)

Contacts

CONTACTÖZLEM KAPUSUZ KÖRDUMAN, MD
zlmkpsz@hotmail.com+905058002027
CONTACTGüldeniz Argun, Prof
guldargun@yahoo.com05336230405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026